Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Maravai LifeSciences (NASDAQ: MRVI) is a leading life sciences company providing critical products and services to enable the development of drug therapies, diagnostics, novel vaccines, and research worldwide. Maravai's companies are leaders in providing products and services in the fields of nucleic acid production and biologics safety testing to many of the world's leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies. Their core offerings include high-quality nucleic acid products, custom antibody and protein products, and comprehensive biologics safety testing services.
Serves as the central hub for executive leadership, corporate strategy, finance, legal, and administrative operations, overseeing the company's global activities and subsidiary businesses.
Located in a modern business park, offering contemporary office spaces and proximity to other biotech companies and research institutions.
Fosters a collaborative, innovative, and science-driven environment, focused on quality, customer success, and advancing life sciences. Employees are often mission-driven, contributing to impactful advancements in medicine.
Its San Diego location places Maravai at the heart of a vibrant biotech ecosystem, facilitating collaborations, talent acquisition, and staying at the forefront of scientific advancements.
Maravai LifeSciences supports a global customer base through its specialized subsidiaries. While its primary manufacturing, R&D, and operational sites are located in the United States, its products—including nucleic acids, biologics safety testing kits, and synthesis reagents—are distributed and utilized by biopharmaceutical companies, diagnostic developers, and research institutions worldwide. This global reach is facilitated through direct sales channels, strategic distribution partners, and dedicated customer support, enabling Maravai to serve markets across North America, Europe, Asia-Pacific, and other regions involved in life sciences research and biopharmaceutical production.
10770 Wateridge Circle, Suite 200
San Diego
CA
USA
Address: 4701 Southport-Supply Rd SE, Southport, NC 28461, USA
Supports the biopharmaceutical industry's global needs for robust and reliable impurity testing solutions, with a focus on product development, manufacturing, and quality control for these critical assays.
Address: 22825 Davis Drive, Sterling, VA 20164, USA
Serves the global market for oligonucleotide synthesis reagents, supporting academic research, pharmaceutical development, and diagnostic applications requiring custom DNA and RNA.
Address: 1000 N. Alternate A1A, Suite 106, Jupiter, FL 33477, USA
Provides specialized enzyme manufacturing capabilities, supporting innovation in molecular diagnostics, next-generation sequencing (NGS), and synthetic biology research and commercialization.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Maravai LifeSciences' leadership includes:
Maravai LifeSciences has been backed by several prominent investors over the years, including:
The most significant executive change in the past year (Nov 2022 - Nov 2023 period, extended to recent) was the transition of Carl Hull from CEO to Executive Chairman, and the appointment of William 'Trey' Martin, III as the new Chief Executive Officer in November 2023, marking a key leadership evolution for the company.
Discover the tools Maravai LifeSciences uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Maravai LifeSciences primarily uses the email format combining the employee's first initial with their last name. This is a common structure for corporate communications.
[first_initial][last]@maravai.com
Format
jdoe@maravai.com
Example
85%
Success rate
Maravai LifeSciences Investor Relations • May 7, 2024
Maravai LifeSciences announced its financial results for the first quarter ended March 31, 2024. The company reported revenues of $69.0 million and discussed performance across its Nucleic Acid Production and Biologics Safety Testing segments, as well as its outlook for the year....more
Maravai LifeSciences Investor Relations • November 8, 2023
Maravai LifeSciences announced that its Board of Directors appointed William “Trey” Martin, III as Chief Executive Officer, effective November 8, 2023. Carl Hull, the company's co-founder and former CEO, transitioned to the role of Executive Chairman....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Maravai LifeSciences, are just a search away.